Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01517763 · ClinicalTrials.gov registry record · NA
Comparison Study of the ICON™ Auto Series With and Without SensAwake™ and ThermoSmart™ and Conventional Continuous Positive Airway Pressure in Obstructive Sleep Apnea Patients
A NA study, sponsored by Fisher and Paykel Healthcare.
- Terminated
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT01517763 is a NA study that was terminated before completion, run by Fisher and Paykel Healthcare. The registered enrollment target is 32 participants.
The verdict
NCT01517763, a NA study, was terminated before completion, sponsored by Fisher and Paykel Healthcare.
- TERMINATED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
A total of 216 patients will be randomized into a partially single blind, randomized, parallel-arm trial to determine whether the ICON™ AT with SensAwake™ and ThermoSmart™ can improve therapy adherence when compared to standard care with a fixed pressure Continuous Positive Airway Pressure (CPAP) device and compared to a less aesthetically pleasing CPAP device without technologies (AutoCPAP, SensAwake™, ThermoSmart™) in patients previously diagnosed with moderate-severe obstructive sleep apnea (OSA).
Interventions
- DEVICE Conventional CPAP Therapy
- DEVICE Fixed pressure ICON™ without ThermoSmart™
- DEVICE Auto ICON™ with SensAwake™ and ThermoSmart™
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2012-01 |
| Est. Completion | 2014-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01517763
The ClinicalTrials.gov registry entry for NCT01517763 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fisher and Paykel Healthcare, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Conventional CPAP Therapy is the first listed.
NCT01517763 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01517763 about?
NCT01517763 is a clinical study titled "Comparison Study of the ICON™ Auto Series With and Without SensAwake™ and ThermoSmart™ and Conventional Continuous Positive Airway Pressure in Obstructive Sleep Apnea Patients". A total of 216 patients will be randomized into a partially single blind, randomized, parallel-arm trial to determine whether the ICON™ AT with SensAwake™ and ThermoSmart™ can improve therapy adherence when compared to standard care with a fixed pressure Continuous Positive Airway Pressure (CPAP) de...
What is the current status of trial NCT01517763?
This trial is currently terminated. It is a NA study. The enrollment target is 32 participants. The study started on 2012-01. Estimated completion is 2014-09.
What interventions are being tested in trial NCT01517763?
The interventions under investigation include: Conventional CPAP Therapy (DEVICE), Fixed pressure ICON™ without ThermoSmart™ (DEVICE), Auto ICON™ with SensAwake™ and ThermoSmart™ (DEVICE).
Who is sponsoring clinical trial NCT01517763?
This trial is sponsored by Fisher and Paykel Healthcare, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.